Myriad Genetics, Inc. Share Price
Stocks
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
15:27:36 29/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 4.295 USD | +1.30% |
|
+5.72% | -30.89% |
| 09-16 | Myriad Genetics, Inc. Announces Management Changes | CI |
| 09-09 | UBS Adjusts Price Target on Myriad Genetics to $3.60 From $6, Keeps Neutral Rating | MT |
| Market Cap | 406M 357M 337M 306M 575M 38.93B 578M 4.04B 1.56B 19.86B 1.52B 1.49B 63.84B | P/E 2026 * |
-2.67x | P/E 2027 * | -3.39x |
|---|---|---|---|---|---|
| Enterprise Value | 357M 314M 297M 269M 505M 34.23B 508M 3.55B 1.37B 17.47B 1.34B 1.31B 56.12B | EV / Sales 2026 * |
0.46x | EV / Sales 2027 * | 0.4x |
| Free-Float |
95.94% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MYGN | Delayed | |
CBOE
| MYGN | Real-time | |
|
Tradegate
| MYD | Real-time | |
|
Deutsche Boerse AG
| MYD | Delayed | |
|
Börse Stuttgart
| MYD | Delayed | |
|
Boerse Muenchen
| MYD | Real-time |
Last Transcript: Myriad Genetics, Inc.
| 1 day | +1.68% | ||
| 1 week | +5.74% | ||
| Current month | +31.68% | ||
| 1 month | +34.18% | ||
| 3 months | -27.89% | ||
| 6 months | -0.93% | ||
| Current year | -31.06% |
| 1 week | 3.97 |  | 4.34 |
| 1 month | 2.92 | | 4.34 |
| Current year | 2.74 | | 7.15 |
| 1 year | 2.74 | | 8.59 |
| 3 years | 2.74 | | 29.3 |
| 5 years | 2.74 | | 33.18 |
| 10 years | 2.74 | | 50.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samraat Raha
CEO | Chief Executive Officer | 54 | 29/04/2025 |
Benjamin Wheeler
DFI | Director of Finance/CFO | 43 | 15/08/2025 |
Raj Jampa
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
S. Phanstiel
CHM | Chairman | 67 | 22/03/2020 |
Heiner Dreismann
BRD | Director/Board Member | 71 | 09/06/2010 |
Colleen Reitan
BRD | Director/Board Member | 66 | 24/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/09/26 | Tax | Chief Financial Officer | -2,555 | 0.0027% | ||
| 16/09/26 | Free | Executive/Senior Manager | 257,731 | 0.2695% | ||
| 16/09/26 | Other | Executive/Senior Manager | 93,493 | 0.0977% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.68% | +5.74% | -44.94% | -74.75% | 406M | |
| +0.05% | +1.99% | +195.40% | +489.92% | 23.8B | |
| +3.26% | +11.88% | +655.12% | +114.55% | 11.53B | |
| -0.13% | +8.67% | -29.18% | -13.31% | 10.67B | |
| -0.72% | +3.59% | +8.77% | - | 8.97B | |
| 0.00% | -0.54% | +97.08% | +43.45% | 6.51B | |
| +3.94% | +1.14% | -27.39% | -21.90% | 5.81B | |
| -1.56% | +2.44% | +3.64% | -9.70% | 4.46B | |
| -4.05% | -7.21% | +53.55% | +58.57% | 3.7B | |
| +1.43% | +4.95% | -13.29% | -25.37% | 2.9B | |
| Average | +0.46% | +3.34% | +89.88% | +62.39% | 7.88B | |
| Weighted average by Cap. | +0.88% | +4.14% | +160.02% | +187.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 778M 684M 647M 587M 1.1B 74.66B 1.11B 7.75B 2.99B 38.1B 2.92B 2.86B 122B | 821M 722M 683M 619M 1.16B 78.82B 1.17B 8.18B 3.16B 40.22B 3.08B 3.02B 129B |
| Net income | -143M -126M -119M -108M -203M -13.76B -204M -1.43B -551M -7.02B -538M -526M -22.56B | -106M -93.33M -88.25M -80.05M -150M -10.19B -151M -1.06B -408M -5.2B -398M -390M -16.7B |
| Net Debt | -49M -43.09M -40.75M -36.96M -69.41M -4.7B -69.82M -488M -188M -2.4B -184M -180M -7.71B | -74.14M -65.21M -61.66M -55.93M -105M -7.12B -106M -738M -285M -3.63B -278M -272M -11.67B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/09/26 | US$4.255 | +0.35% | 57,829 |
| 28/09/26 | US$4.240 | +1.68% | 1,181,318 |
| 25/09/26 | US$4.170 | +0.72% | 1,648,432 |
| 24/09/26 | US$4.140 | +3.24% | 1,961,359 |
| 23/09/26 | US$4.010 | -0.25% | 1,657,985 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MYGN Stock
Select your edition
All financial news and data tailored to specific country editions
